---
figid: PMC6585552__NRR-14-1713-g001
figlink: /pmc/articles/PMC6585552/figure/F1/
number: F1
caption: 'LRRK2 kinase activity regulates PKA-NFκB p50 inhibitory pathway.Microglial
  cells with LRRK2-G2019S exhibit increased LRRK2-RIIβ interaction and RIIβ phosphorylation
  state and a reduction of PKA-mediated NFκB p50 phosphorylation level, indicative
  of an inhibition state of PKA. Whereas, microglia cells with LRRK2 pharmacological
  inhibition (GSK) exhibit reduced LRRK2-RIIβ interaction and RIIβ phosphorylation
  state, increased cAMP and PKA-mediated NFκB p50 phosphorylation levels, all indicative
  of an activation state of PKA. LRRK2: Leucine-rich repeat kinase; PKA: protein kinase
  A; NFκB: nuclear factor kappa B.'
pmcid: PMC6585552
papertitle: 'The role of LRRK2 on PKA-NFκB pathway in microglia cells: implications
  for Parkinson’s disease.'
reftext: Isabella Russo. Neural Regen Res. 2019 Oct;14(10):1713-1714.
pmc_ranked_result_index: '190313'
pathway_score: 0.8882686
filename: NRR-14-1713-g001.jpg
figtitle: 'The role of LRRK2 on PKA-NFκB pathway in microglia cells: implications
  for Parkinson’s disease.'
year: '2019'
organisms: Homo sapiens
ndex: f1b4ec34-df13-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6585552__NRR-14-1713-g001.html
  '@type': Dataset
  description: 'LRRK2 kinase activity regulates PKA-NFκB p50 inhibitory pathway.Microglial
    cells with LRRK2-G2019S exhibit increased LRRK2-RIIβ interaction and RIIβ phosphorylation
    state and a reduction of PKA-mediated NFκB p50 phosphorylation level, indicative
    of an inhibition state of PKA. Whereas, microglia cells with LRRK2 pharmacological
    inhibition (GSK) exhibit reduced LRRK2-RIIβ interaction and RIIβ phosphorylation
    state, increased cAMP and PKA-mediated NFκB p50 phosphorylation levels, all indicative
    of an activation state of PKA. LRRK2: Leucine-rich repeat kinase; PKA: protein
    kinase A; NFκB: nuclear factor kappa B.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDE4A
  - PDE4B
  - PDE4D
  - PRKACA
  - PRKACB
  - LRRK2
  - PRKAR2A
  - PRKACG
  - PRKAR1A
  - PDE4C
  - PRKAR1B
  - PRKAR2B
  - 5'AMP
genes:
- word: PDE4
  symbol: PDE4
  source: bioentities_symbol
  hgnc_symbol: PDE4A
  entrez: '5141'
- word: PDE4
  symbol: PDE4
  source: bioentities_symbol
  hgnc_symbol: PDE4B
  entrez: '5142'
- word: PDE4
  symbol: PDE4
  source: bioentities_symbol
  hgnc_symbol: PDE4D
  entrez: '5144'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: LRRK2
  symbol: LRRK2
  source: hgnc_symbol
  hgnc_symbol: LRRK2
  entrez: '120892'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PDE4
  symbol: PDE4
  source: bioentities_symbol
  hgnc_symbol: PDE4C
  entrez: '5143'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
chemicals:
- word: 5'AMP
  source: MESH
  identifier: D000249
diseases: []
figid_alias: PMC6585552__F1
redirect_from: /figures/PMC6585552__F1
figtype: Figure
---
